Author correction to ‘VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity’ [Acta Pharm Sin B 11 (2021) 420–433]

• Pengzhao Shang,
• Rui Gao,
• Yijia Zhu,
• Xiaorui Zhang,
• Yang Wang,
• Minji Guo,
• Hui Peng,
• Min Wang,
• Juan Zhang

Affiliations

Pengzhao Shang

Antibody Engineering Laboratory, School of Life Science & Technology, China Pharmaceutical University, Nanjing 210009, China

Rui Gao

Antibody Engineering Laboratory, School of Life Science & Technology, China Pharmaceutical University, Nanjing 210009, China

Yijia Zhu

Antibody Engineering Laboratory, School of Life Science & Technology, China Pharmaceutical University, Nanjing 210009, China

Xiaorui Zhang

Antibody Engineering Laboratory, School of Life Science & Technology, China Pharmaceutical University, Nanjing 210009, China

Yang Wang

Antibody Engineering Laboratory, School of Life Science & Technology, China Pharmaceutical University, Nanjing 210009, China

Minji Guo

Antibody Engineering Laboratory, School of Life Science & Technology, China Pharmaceutical University, Nanjing 210009, China

Hui Peng

Department of Operational Medicine, Tianjin Institute of Environmental & Operational Medicine, Tianjin 300050, China

Min Wang

Antibody Engineering Laboratory, School of Life Science & Technology, China Pharmaceutical University, Nanjing 210009, China

Juan Zhang

Antibody Engineering Laboratory, School of Life Science & Technology, China Pharmaceutical University, Nanjing 210009, China; Corresponding author.